WO2007082757A3 - Systemes de tests pour l’analyse de polypeptides et de cellules adherant a des silicones - Google Patents

Systemes de tests pour l’analyse de polypeptides et de cellules adherant a des silicones Download PDF

Info

Publication number
WO2007082757A3
WO2007082757A3 PCT/EP2007/000442 EP2007000442W WO2007082757A3 WO 2007082757 A3 WO2007082757 A3 WO 2007082757A3 EP 2007000442 W EP2007000442 W EP 2007000442W WO 2007082757 A3 WO2007082757 A3 WO 2007082757A3
Authority
WO
WIPO (PCT)
Prior art keywords
polypeptides
test systems
silicone
silicones
analysis
Prior art date
Application number
PCT/EP2007/000442
Other languages
English (en)
Other versions
WO2007082757A2 (fr
Inventor
Georg Wick
Nikolaus Wick
Aleksander Backovic
Original Assignee
Idc Immunological Diagnostic A
Georg Wick
Nikolaus Wick
Aleksander Backovic
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP06001053A external-priority patent/EP1811297A1/fr
Application filed by Idc Immunological Diagnostic A, Georg Wick, Nikolaus Wick, Aleksander Backovic filed Critical Idc Immunological Diagnostic A
Priority to AU2007207089A priority Critical patent/AU2007207089A1/en
Priority to BRPI0706553-1A priority patent/BRPI0706553A2/pt
Priority to US12/160,996 priority patent/US20110135606A1/en
Priority to CA002636353A priority patent/CA2636353A1/fr
Priority to JP2008550689A priority patent/JP2009524031A/ja
Publication of WO2007082757A2 publication Critical patent/WO2007082757A2/fr
Publication of WO2007082757A3 publication Critical patent/WO2007082757A3/fr

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G01N33/5023—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects on expression patterns
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5091—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physiology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La présente invention concerne de manière générale le champ du diagnostic, à savoir des systèmes de tests de polypeptides par rapport à la silicone. Plus précisément, la présente invention concerne dans l’un de ses modes de réalisation des systèmes de tests pour l’identification et l’analyse de polypeptides adhérant à la silicone. De plus, la présente invention concerne des polypeptides adhérant à la silicone récemment identifiés et les utilisations respectives de telles protéines, p. ex. dans des systèmes de tests visant à détecter une réaction d’un mammifère en réponse à une silicone.
PCT/EP2007/000442 2006-01-18 2007-01-18 Systemes de tests pour l’analyse de polypeptides et de cellules adherant a des silicones WO2007082757A2 (fr)

Priority Applications (5)

Application Number Priority Date Filing Date Title
AU2007207089A AU2007207089A1 (en) 2006-01-18 2007-01-18 Test systems for the analysis of polypeptides and cells adhering to silicones
BRPI0706553-1A BRPI0706553A2 (pt) 2006-01-18 2007-01-18 sistemas de testes para a análise de polipéptidos e células que aderem a silicones
US12/160,996 US20110135606A1 (en) 2006-01-18 2007-01-18 Test systems for the analysis of polypeptides and cells adhering to silicones
CA002636353A CA2636353A1 (fr) 2006-01-18 2007-01-18 Systemes de tests pour l'analyse de polypeptides et de cellules adherant a des silicones
JP2008550689A JP2009524031A (ja) 2006-01-18 2007-01-18 シリコンに接着するポリペプチドおよび細胞を分析するための試験系

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP06001053A EP1811297A1 (fr) 2006-01-18 2006-01-18 Des systèmes de test pour l'analyse de polypeptides et des cellules adhérant à des silicones
EP06001053.5 2006-01-18
US76042606P 2006-01-20 2006-01-20
US60/760,426 2006-01-20

Publications (2)

Publication Number Publication Date
WO2007082757A2 WO2007082757A2 (fr) 2007-07-26
WO2007082757A3 true WO2007082757A3 (fr) 2007-09-20

Family

ID=38042562

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2007/000442 WO2007082757A2 (fr) 2006-01-18 2007-01-18 Systemes de tests pour l’analyse de polypeptides et de cellules adherant a des silicones

Country Status (4)

Country Link
JP (1) JP2009524031A (fr)
AU (1) AU2007207089A1 (fr)
CA (1) CA2636353A1 (fr)
WO (1) WO2007082757A2 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104193817B (zh) * 2014-09-05 2016-09-14 桂林英美特生物技术有限公司 人视黄醇结合蛋白的纯化工艺及其多克隆抗体的制备工艺

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003024429A1 (fr) 2001-09-21 2003-03-27 Egalet A/S Systeme de liberation a base de polymere
US20040253310A1 (en) 2001-09-21 2004-12-16 Gina Fischer Morphine polymer release system
US8877241B2 (en) 2003-03-26 2014-11-04 Egalet Ltd. Morphine controlled release system
PL2614832T3 (pl) 2007-02-12 2017-01-31 A1M Pharma Ab Diagnostyka i leczenie stanu przedrzucawkowego
EP2155167A2 (fr) 2007-06-04 2010-02-24 Egalet A/S Compositions pharmaceutiques à libération contrôlée pour un effet prolongé
WO2009055427A2 (fr) 2007-10-22 2009-04-30 Becton, Dickinson And Company Procédés d'évaluation de l'agrégation d'une protéine dans une suspension comprenant un organopolysiloxane et articles médicaux recouverts d'un organopolysiloxane contenant une solution protéique
CA2751667C (fr) 2009-02-06 2016-12-13 Egalet Ltd. Composition a liberation immediate resistant a une maltraitance par prise d'alcool
BR102014004679B1 (pt) * 2014-02-27 2021-04-20 Fundação Oswaldo Cruz método preditivo para diagnóstico diferencial de meningites in vitro, uso de proteínas biomarcadoras, e, kit para diagnóstico diferencial de meningites para determinar se um indivíduo possui meningites bacterianas ou meningites virais
WO2017137570A1 (fr) 2016-02-10 2017-08-17 Becton Dickinson France Procédé pour évaluer la stabilité de formulation à base de protéine

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5834215A (en) * 1994-10-05 1998-11-10 The Administrators Of The Tulane Educational Fund Method for detecting antipolymer antibodies and diagnosing silicone related disease (SRD) fibromyalgia and chronic fatigue syndrome (CFS)

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
BACKOVIC, A.; OBERREITER, B.; DEL FRARI, B.; HUANG, H. L.; PIZA, H.; WICK, G.: "Joint Annual Meeting of the German and Scandinavian Societies of Immunology, 21-24 September 2005, Kiel, Germany", IMMUNOBIOLOGY, FISCHER, STUTTGART, DE, vol. 210, no. 6-8, 15 September 2005 (2005-09-15), pages 490, XP005047744, ISSN: 0171-2985 *
HU W J ET AL: "Molecular basis of biomaterial-mediated foreign body reactions.", BLOOD 15 AUG 2001, vol. 98, no. 4, 15 August 2001 (2001-08-15), pages 1231 - 1238, XP002435212, ISSN: 0006-4971 *
HUNT J A ET AL: "Techniques to investigate cellular and molecular interactions in the host response to implanted biomaterials", BIOMATERIALS, ELSEVIER SCIENCE PUBLISHERS BV., BARKING, GB, vol. 18, no. 22, November 1997 (1997-11-01), pages 1449 - 1459, XP004096110, ISSN: 0142-9612 *
SELLBORN A ET AL: "Immune complement activation on polystyrene and silicon dioxide surfaces - Impact of reversible IgG adsorption", MOLECULAR IMMUNOLOGY, ELMSFORD, NY, US, vol. 42, no. 5, March 2005 (2005-03-01), pages 569 - 574, XP004686615, ISSN: 0161-5890 *
WOLFRAM DOLORES ET AL: "Cellular and molecular composition of fibrous capsules formed around silicone breast implants with special focus on local immune reactions.", JOURNAL OF AUTOIMMUNITY. AUG 2004, vol. 23, no. 1, August 2004 (2004-08-01), pages 81 - 91, XP002375203, ISSN: 0896-8411 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104193817B (zh) * 2014-09-05 2016-09-14 桂林英美特生物技术有限公司 人视黄醇结合蛋白的纯化工艺及其多克隆抗体的制备工艺

Also Published As

Publication number Publication date
WO2007082757A2 (fr) 2007-07-26
AU2007207089A1 (en) 2007-07-26
JP2009524031A (ja) 2009-06-25
CA2636353A1 (fr) 2007-07-26

Similar Documents

Publication Publication Date Title
WO2007082757A3 (fr) Systemes de tests pour l’analyse de polypeptides et de cellules adherant a des silicones
EP1873533A4 (fr) Puce de test destinee a l analyse d echantillons et systeme de microanalyse
WO2009134944A3 (fr) Procédés de détermination de l'état de santé d'un individu
WO2008039946A3 (fr) Dispositif de mesure intégré pour l'analyse d'échantillons biologiques
WO2007140291A3 (fr) Quantification d'expression par spectrométrie de masse
WO2008066584A3 (fr) Dosage rapide de mesure d'analyte
WO2008066629A3 (fr) Procédés d'analyse protéomique quantitative de glyoprotéines
WO2007114986A3 (fr) Sondes coopératives et leurs procédés d'utilisation
GB2439032B (en) Method and system for sample testing
EP1887363A4 (fr) Micro système d analyse globale, puce d examen et procédé d examen
DE602007011937D1 (de) Peptidantikörperdepletion und anwendung zur probenvorbereitung für massenspektrometrie
CR20110567A (es) Dispositivos para diagnostico y metodos relacionados
MX2009006600A (es) Analizador de muestras.
EP2340301A4 (fr) Analyseur d imagerie pour essai d analytes
EP1882950A4 (fr) Puce de test pour analyser une substance cible dans une substance à analyser et système analytique à l'échelle microscopique
EP2021512A4 (fr) Systèmes et procédés destinés à développer des tests diagnostiques sur la base d'informations de biomarqueurs provenant d'ensembles d'échantillons cliniques existants
EP2061599A4 (fr) Procede permettant de tester un echantillon de liquide, unite de test et systeme automatise d'une pluralite d'unites de test
HK1119778A1 (en) Method for analyzing a sample on a test element and analysis system
WO2008151207A3 (fr) Quantification d'expression utilisant une spectrométrie de masse
TR201900481T4 (tr) Bağışıklık testi için aparat ve kit.
MX2009013009A (es) Inmunoensayos de alta sensibilidad y kits para la determinacion de peptidos y proteinas de interes biologico.
WO2009142835A3 (fr) Procédé et appareil destinés à analyser la peau et les cheveux
WO2008003764A3 (fr) Procédé et système d'essai de logiciels
WO2010061283A3 (fr) Biomarqueurs pour diagnostiquer et détecter la progression de troubles neurodégénératifs, en particulier de la sclérose latérale amyotrophique
WO2013010134A3 (fr) Systèmes, appareils et procédés d'analyse biochimique à haut débit

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 5577/DELNP/2008

Country of ref document: IN

WWE Wipo information: entry into national phase

Ref document number: 2636353

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2008550689

Country of ref document: JP

WWE Wipo information: entry into national phase

Ref document number: 200780002627.9

Country of ref document: CN

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2007207089

Country of ref document: AU

WWP Wipo information: published in national office

Ref document number: 2007207089

Country of ref document: AU

122 Ep: pct application non-entry in european phase

Ref document number: 07702875

Country of ref document: EP

Kind code of ref document: A2

WWE Wipo information: entry into national phase

Ref document number: 12160996

Country of ref document: US

ENP Entry into the national phase

Ref document number: PI0706553

Country of ref document: BR

Kind code of ref document: A2

Effective date: 20080715